Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-05-06 07:00 |
Valneva annonce la fixation du prix de ses titres pour son introduction sur le …
|
French | 347.9 KB | ||
| 2021-05-06 07:00 |
Valneva Announces the Pricing of its Initial Public Offering on Nasdaq
|
English | 180.9 KB | ||
| 2021-05-05 07:00 |
Valneva Announces an Indicative Price Range of its Previously Announced Propose…
|
English | 143.1 KB | ||
| 2021-05-05 07:00 |
Valneva annonce une fourchette de prix indicative pour son projet d’offre globa…
|
French | 231.9 KB | ||
| 2021-04-29 07:00 |
Valneva annonce le lancement de son projet d’offre globale et d'introduction su…
|
French | 437.9 KB | ||
| 2021-04-29 07:00 |
Valneva Announces Launch of Proposed Global Offering, Start of the Roadshow and…
|
English | 164.3 KB | ||
| 2021-04-21 22:00 |
Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-…
|
English | 394.3 KB | ||
| 2021-04-21 22:00 |
Valneva initie une étude clinique de Phase 3 pour son candidat vaccin inactivé …
|
French | 666.8 KB | ||
| 2021-04-20 23:59 |
Valneva se tourne vers des discussions bilatérales pour la fourniture de son va…
|
French | 588.3 KB | ||
| 2021-04-20 23:59 |
Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adju…
|
English | 411.9 KB | ||
| 2021-04-13 16:14 |
Franchissement de seuil
|
French | 199.9 KB | ||
| 2021-04-12 17:35 |
Valneva Completes Recruitment for Pivotal Phase 3 Trial of Chikungunya Vaccine …
|
English | 320.2 KB | ||
| 2021-04-12 17:35 |
Valneva finalise le recrutement pour l’étude pivot de Phase 3 de son candidat v…
|
French | 623.5 KB | ||
| 2021-04-10 08:00 |
Valneva annonce le dépôt d'un document d'enregistrement « Form F-1 » dans le ca…
|
French | 404.0 KB | ||
| 2021-04-10 08:00 |
Valneva Announces Publication of 2020 Universal Registration Document and Provi…
|
English | 307.3 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
